Cargando…

Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders

Cognitive impairment is a shared abnormality between type 2 diabetes mellitus (T2DM) and many neurodegenerative and neuropsychiatric disorders, such as Alzheimer’s disease (AD) and schizophrenia. Emerging evidence suggests that brain insulin resistance plays a significant role in cognitive deficits,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qian, Cao, Ting, Li, NaNa, Zeng, Cuirong, Zhang, Shuangyang, Wu, Xiangxin, Zhang, Bikui, Cai, Hualin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182376/ https://www.ncbi.nlm.nih.gov/pubmed/34108878 http://dx.doi.org/10.3389/fphar.2021.667874

Ejemplares similares

A Potential Mechanism Underlying the Therapeutic Effects of Progesterone and Allopregnanolone on Ketamine-Induced Cognitive Deficits
por: Cao, Ting, et al.
Publicado: (2021)

Clozapine Induced Disturbances in Hepatic Glucose Metabolism: The Potential Role of PGRMC1 Signaling
por: Cao, Ting, et al.
Publicado: (2021)

Effect of Probiotic Supplements on Oxidative Stress Biomarkers in First-Episode Bipolar Disorder Patients: A Randomized, Placebo-Controlled Trial
por: Zeng, Cuirong, et al.
Publicado: (2022)

Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis
por: Zhu, Zhenyu, et al.
Publicado: (2022)

Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders
por: Shah, Sweta, et al.
Publicado: (2021)

Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
por: Jung, Yoo Jin, et al.
Publicado: (2021)

The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications
por: Chen, Hui, et al.
Publicado: (2023)

Repurposing Tranexamic Acid as an Anticancer Agent
por: Law, Mary E., et al.
Publicado: (2022)

Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs
por: Li, Nana, et al.
Publicado: (2020)

Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities
por: Chaffey, Laura, et al.
Publicado: (2022)

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
por: Porta, Exequiel O. J., et al.
Publicado: (2023)

Isoliquiritigenin Alleviates Semen Strychni-Induced Neurotoxicity by Restoring the Metabolic Pathway of Neurotransmitters in Rats
por: Wang, Lu, et al.
Publicado: (2021)

The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light
por: Collingwood, Joanna F., et al.
Publicado: (2014)

Neuroprotective Potency of Saffron Against Neuropsychiatric Diseases, Neurodegenerative Diseases, and Other Brain Disorders: From Bench to Bedside
por: Bian, Yaqi, et al.
Publicado: (2020)

Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management
por: Saggam, Akash, et al.
Publicado: (2021)

Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders
por: Lee, Hyeong-Min, et al.
Publicado: (2016)

Allergic Asthma-Induced Cognitive Impairment is Alleviated by Dexamethasone
por: Ren, Mengli, et al.
Publicado: (2021)

Stachyose Alleviates Corticosterone-Induced Long-Term Potentiation Impairment via the Gut–Brain Axis
por: Huang, Yan, et al.
Publicado: (2022)

Impaired autophagy: a link between neurodegenerative and neuropsychiatric diseases
por: Polajnar, Mira, et al.
Publicado: (2014)

Analysis methods for the gut microbiome in neuropsychiatric and neurodegenerative disorders
por: Song, Jae Gwang, et al.
Publicado: (2022)

Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection
por: Al-Motawa, Maryam S., et al.
Publicado: (2020)

Mitoprotective Effects of Centella asiatica (L.) Urb.: Anti-Inflammatory and Neuroprotective Opportunities in Neurodegenerative Disease
por: Wong, Jia Hui, et al.
Publicado: (2021)

Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease
por: Nixon, Gemma L., et al.
Publicado: (2018)

Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer
por: Tan, George S. Q., et al.
Publicado: (2023)

DL-3-n-butylphthalide (NBP) alleviates poststroke cognitive impairment (PSCI) by suppressing neuroinflammation and oxidative stress
por: Zhang, Hui, et al.
Publicado: (2023)

Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors
por: Ren, Si-yu, et al.
Publicado: (2020)

Mechanisms of Triptolide-Induced Hepatotoxicity and Protective Effect of Combined Use of Isoliquiritigenin: Possible Roles of Nrf2 and Hepatic Transporters
por: Hou, Zhenyan, et al.
Publicado: (2018)

The emerging role of furin in neurodegenerative and neuropsychiatric diseases
por: Zhang, Yi, et al.
Publicado: (2022)

Impairment of Interrelated Iron- and Copper Homeostatic Mechanisms in Brain Contributes to the Pathogenesis of Neurodegenerative Disorders
por: Skjørringe, Tina, et al.
Publicado: (2012)

Recent Progress in Environmental Toxins-Induced Cardiotoxicity and Protective Potential of Natural Products
por: Yang, Yuanying, et al.
Publicado: (2021)

Venlafaxine Improves the Cognitive Impairment and Depression-Like Behaviors in a Cuprizone Mouse Model by Alleviating Demyelination and Neuroinflammation in the Brain
por: Zhang, Yanbo, et al.
Publicado: (2019)

Fresh Gastrodia elata Blume alleviates simulated weightlessness-induced cognitive impairment by regulating inflammatory and apoptosis-related pathways
por: Zhang, Yiwen, et al.
Publicado: (2023)

Repurposing of Bromocriptine for Cancer Therapy
por: Seo, Ean-Jeong, et al.
Publicado: (2018)

Neuropsychiatric Disorders in Chronic Kidney Disease
por: Simões e Silva, Ana Cristina, et al.
Publicado: (2019)

Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

The role of hand preference in cognition and neuropsychiatric symptoms in neurodegenerative diseases
por: Saari, Toni T, et al.
Publicado: (2023)

Shexiang Baoxin Pill, a Proprietary Multi-Constituent Chinese Medicine, Prevents Locomotor and Cognitive Impairment Caused by Brain Ischemia and Reperfusion Injury in Rats: A Potential Therapy for Neuropsychiatric Sequelae of Stroke
por: Qin, Zong-Shi, et al.
Publicado: (2021)

Disulfiram in glioma: Literature review of drug repurposing
por: Zhong, Shiyu, et al.
Publicado: (2022)

Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders()
por: Khatri, Dharmendra Kumar, et al.
Publicado: (2021)

Moringa oleifera Seed Extract Alleviates Scopolamine-Induced Learning and Memory Impairment in Mice
por: Zhou, Juan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p947k4smvavk2r6d1pb6j0kt9d